The formation of amyloidosis lesions is associated with amyloid peptides, and by constructing CRP-associated mutants, researchers have found that the mutants almost always bind to amyloid-β peptide and prevent fibril formation, suggesting that CRP can exert an anti-amyloidogenic effect and thus inhibit the amyloidosis process [73]. Here, PPIB is linked to amyloidosis.